Quick Answer
Cyclerion Therapeutics, Inc. reported Shares Outstanding of 3.82 million shares for fiscal year 2025.
Cyclerion Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.82M | +50.1% |
| 2024 | 2.55M | +2.9% |
| 2023 | 2.47M | +13.7% |
| 2022 | 2.18M | -95.0% |
| 2021 | 43.41M | +27.5% |
| 2020 | 34.05M | +23.4% |
| 2019 | 27.60M | — |
| 2018 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.70M | +46.0% | +20.1% |
| June 30, 2025 | 3.08M | +22.3% | +0.5% |
| March 31, 2025 | 3.06M | +22.5% | +20.2% |
| December 31, 2024 | 2.55M | +2.9% | +0.6% |
| September 30, 2024 | 2.53M | +3.5% | +0.6% |
| June 30, 2024 | 2.52M | +4.5% | +0.7% |
| March 31, 2024 | 2.50M | -94.3% | +1.0% |
| December 31, 2023 | 2.47M | +13.7% | +1.2% |
- Cyclerion Therapeutics, Inc. showed an increase of +50.1% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Cyclerion Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: